Results 181 to 190 of about 2,748,395 (254)
Prolonged Somatostatin Receptor 2 Antagonism Enhances Glucagon Response to Hypoglycemia in Male Diabetic Rats. [PDF]
D'Souza NC +9 more
europepmc +1 more source
Hypoglycemia secondary to type B insulin resistance syndrome. [PDF]
Naidoo P, Pirie FJ, Paruk IM.
europepmc +1 more source
A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Efficacy and Adverse Events. [PDF]
Radparvar I, Agrawal DK.
europepmc +1 more source
Glucagonoma of the pancreas: diagnostic approach and therapeutic algorithm for a rare nosological entity. [PDF]
Mastoraki A +13 more
europepmc +1 more source
Beyond Diabetes: A Review of Emerging Indications for Glucagon-Like Peptide-1 Receptor Agonists. [PDF]
West L +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Glucagon and glucagon-like peptide receptors as drug targets.
Current Pharmaceutical Design, 2006Glucagon and the glucagon-like peptides are derived from a common proglucagon precursor, and regulate energy homeostasis through interaction with a family of distinct G protein coupled receptors. Three proglucagon-derived peptides, glucagon, GLP-1, and GLP-2, play important roles in energy intake, absorption, and disposal, as elucidated through studies
J. Estall, D. Drucker
semanticscholar +3 more sources

